MARKET

VCYT

VCYT

Veracyte
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.23
+0.52
+2.29%
After Hours: 22.91 -0.32 -1.39% 16:11 04/08 EDT
OPEN
23.10
PREV CLOSE
22.71
HIGH
23.38
LOW
22.23
VOLUME
589.89K
TURNOVER
--
52 WEEK HIGH
31.18
52 WEEK LOW
13.90
MARKET CAP
1.16B
P/E (TTM)
-86.6468
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VCYT stock price target is 32.80 with a high estimate of 35.00 and a low estimate of 30.00.

EPS

VCYT News

More
  • Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations
  • Business Wire · 1d ago
  • Veracyte, Inc. (NASDAQ:VCYT): When Will It Breakeven?
  • Simply Wall St. · 6d ago
  • Veracyte Announces Novel Gene Fusion Detection with the Afirma Xpression Atlas, Which May Inform Targeted Treatment Decisions for Thyroid Cancer Patients
  • Business Wire · 04/01 13:15
  • The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
  • Benzinga · 03/13 11:52

Industry

Biotechnology & Medical Research
+3.08%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About VCYT

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.
More

Webull offers kinds of Veracyte Inc stock information, including NASDAQ:VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions.